GlycoMar Limited - Product Pipeline Review - 2014
GlycoMar Limited - Product Pipeline Review - 2014
Summary
Global Markets...
glycomar Limited - Pipeline Products Glance 13
glycomar Limited - Early Stage Pipeline Products 13
preclinical Products/co...
research needs spanning across industry verticals with our huge collection of market research reports. We provide our serv...
Upcoming SlideShare
Loading in …5
×

Researchmoz | GlycoMar Limited - Product Pipeline Review - 2014

311 views

Published on

This report provides comprehensive information on the current therapeutic developmental pipeline of GlycoMar Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Get Detail Report With TOC @ http://www.researchmoz.us/glycomar-limited-product-pipeline-review-2014-report.html

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Published in: Business, News & Politics
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
311
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Researchmoz | GlycoMar Limited - Product Pipeline Review - 2014

  1. 1. GlycoMar Limited - Product Pipeline Review - 2014 GlycoMar Limited - Product Pipeline Review - 2014 Summary Global Markets Directs, GlycoMar Limited - Product Pipeline Review - 2014, provides an overview of the GlycoMar Limiteds pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of GlycoMar Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of GlycoMar Limited including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of GlycoMar Limiteds human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the GlycoMar Limiteds pipeline products Reasons to buy - Evaluate GlycoMar Limiteds strategic position with total access to detailed information on its product pipeline - Assess the growth potential of GlycoMar Limited in its therapy areas of focus - Identify new drug targets and therapeutic classes in the GlycoMar Limiteds R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of GlycoMar Limited and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of GlycoMar Limited - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of GlycoMar Limited and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 4 glycomar Limited Snapshot 5 glycomar Limited Overview 5 key Information 5 key Facts 5 glycomar Limited - Research And Development Overview 6 key Therapeutic Areas 6 glycomar Limited - Pipeline Review 9 pipeline Products By Stage Of Development 9 pipeline Products - Monotherapy 10 pipeline Products - Partnered Products 11 partnered Products/combination Treatment Modalities 12 GlycoMar Limited - Product Pipeline Review - 2014
  2. 2. glycomar Limited - Pipeline Products Glance 13 glycomar Limited - Early Stage Pipeline Products 13 preclinical Products/combination Treatment Modalities 13 discovery Products/combination Treatment Modalities 14 glycomar Limited - Drug Profiles 15 gly-145 15 product Description 15 mechanism Of Action 15 r&d Progress 15 gly-2028 16 product Description 16 mechanism Of Action 16 r&d Progress 16 gly-079 17 product Description 17 mechanism Of Action 17 r&d Progress 17 gly-198 18 product Description 18 mechanism Of Action 18 r&d Progress 18 glyk-5006 19 product Description 19 mechanism Of Action 19 r&d Progress 19 inflammatory Bowel Disease Program 20 product Description 20 mechanism Of Action 20 r&d Progress 20 glycomar Limited - Pipeline Analysis 21 glycomar Limited - Pipeline Products By Target 21 glycomar Limited - Pipeline Products By Route Of Administration 22 glycomar Limited - Pipeline Products By Molecule Type 23 glycomar Limited - Pipeline Products By Mechanism Of Action 24 glycomar Limited - Locations And Subsidiaries 25 head Office 25 appendix 26 methodology 26 coverage 26 secondary Research 26 primary Research 26 expert Panel Validation 26 contact Us 27 disclaimer 27 list Of Tables glycomar Limited, Key Information 5 glycomar Limited, Key Facts 5 glycomar Limited - Pipeline By Indication, 2014 8 glycomar Limited - Pipeline By Stage Of Development, 2014 9 glycomar Limited - Monotherapy Products In Pipeline, 2014 10 glycomar Limited - Partnered Products In Pipeline, 2014 11 glycomar Limited - Partnered Products/ Combination Treatment Modalities, 2014 12 glycomar Limited - Preclinical, 2014 13 glycomar Limited - Discovery, 2014 14 glycomar Limited - Pipeline By Target, 2014 21 glycomar Limited - Pipeline By Route Of Administration, 2014 22 glycomar Limited - Pipeline By Molecule Type, 2014 23 glycomar Limited - Pipeline Products By Mechanism Of Action, 2014 24 list Of Figures glycomar Limited - Pipeline By Top 10 Indication, 2014 7 glycomar Limited - Pipeline By Stage Of Development, 2014 9 glycomar Limited - Monotherapy Products In Pipeline, 2014 10 glycomar Limited - Pipeline By Top 10 Route Of Administration, 2014 22 glycomar Limited - Pipeline By Top 10 Molecule Type, 2014 23 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your GlycoMar Limited - Product Pipeline Review - 2014
  3. 3. research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ GlycoMar Limited - Product Pipeline Review - 2014

×